vasoactive-intestinal-peptide and Myasthenia-Gravis

vasoactive-intestinal-peptide has been researched along with Myasthenia-Gravis* in 3 studies

Other Studies

3 other study(ies) available for vasoactive-intestinal-peptide and Myasthenia-Gravis

ArticleYear
Neuropeptides of human thymus in normal and pathological conditions.
    Peptides, 2011, Volume: 32, Issue:5

    Human thymus of healthy subjects and patients affected by thymoma-associated Myastenia Gravis were studied in order to visualize and compare the morphological distributive pattern of four neuropeptides: vasoactive intestinal peptide, substance P, neuropeptide Y, and neurotensin. Based on our observations, we formulated hypotheses on their relations in neuro-immunomodulation under physiological and pathophysiological conditions. Immuno-histochemical staining for neuropeptides was performed and morphological and morphometrical analyses were conducted on healthy and diseased thymus. In normal thymus, a specific distributive pattern was observed for the several neuropeptide-positive nerves in different thymus lobular zones. In particular substance P-positive fibers were observed in subcapsular zone, specifically located into parenchyma, where they represent the almost total amount of fibers; neurotensin-positive fibers were observed primarily located in parenchyma than perivascular site of several thymus lobular zones, and more abundant the cortico-medullary and medullary zones. Instead VIP- and NPY-positive fibers were widely distributed in perivascular and parenchymal sites of several thymus lobular zones. In thymoma, the distribution of neuropeptide-positive fibers was quantitatively reduced, while cells immunopositive to VIP and substance P were quantitatively increased and dispersed. Observation of the perivascular and parenchymal distribution of the analyzed neuropeptides suggests evidence that a regulatory function is performed by nerves and cells that secrete neuropeptide into the thymus. The alteration of neuropeptide patterns in thymoma suggests that these neurotransmitters play a role in autoimmune diseases such as Myastenia Gravis.

    Topics: Adult; Humans; Immunohistochemistry; Male; Myasthenia Gravis; Neuropeptide Y; Neuropeptides; Neurotensin; Substance P; Thymoma; Thymus Gland; Vasoactive Intestinal Peptide

2011
Functional expression of receptors for calcitonin gene-related peptide, calcitonin, and vasoactive intestinal peptide in the human thymus and thymomas from myasthenia gravis patients.
    Journal of immunology (Baltimore, Md. : 1950), 1999, Feb-15, Volume: 162, Issue:4

    The molecular and functional expression of serpentine membrane receptors for vasoactive intestinal peptide (VIP), calcitonin gene-related peptide (CGRP), and calcitonin (CT) were characterized in human thymus and thymomas from myasthenia gravis (MG) patients and thymic epithelial cells either in primary culture (PTEC) or transformed by the simian virus 40 large T (SV40LT) oncogene (LT-TEC). Using RT-PCR combined with Southern analysis, we identified the PCR products corresponding to the receptor (-R) transcripts for VIP, CGRP, and CT in thymus from control subjects and MG patients with either hyperplasia or thymoma. Similar expressions of the VIP- and CGRP-R transcripts were observed in PTEC, whereas the CT-R message was not detected. In LT-TEC, the signals for VIP-R, CGRP-R, and CT-R transcripts were seen with a lower intensity than those in control and MG thymus. In agreement with our molecular analysis, 1) VIP was the most potent peptide among VIP-related peptides (VIP > PACAP > PHM > PHV) to stimulate cAMP production through specific type 1 VIP receptors in both PTEC and LT-TEC; 2) cAMP generation was induced by CGRP in PTEC and by CT in LT-TEC; 3) in frozen thymic sections and by flow cytometry, type 1 VIP-R, CGRP-R, and CT-R were localized in epithelial cells; and 4) in parallel, the transcription of the acetylcholine receptor alpha subunit (the main autoantigen in MG) was induced by CGRP and CT in PTEC and LT-TEC, respectively. Our data suggest that the neuroendocrine peptides VIP, CGRP, and CT may exert functional roles during MG and malignant transformation of the human thymus.

    Topics: Adolescent; Adult; Antigens, Viral, Tumor; Blotting, Southern; Calcitonin; Calcitonin Gene-Related Peptide; Cell Culture Techniques; Cell Line, Transformed; Cell Transformation, Viral; Child; Child, Preschool; Epithelial Cells; Flow Cytometry; Gene Expression Regulation; Humans; Immunohistochemistry; Infant; Middle Aged; Myasthenia Gravis; Receptors, Calcitonin; Receptors, Calcitonin Gene-Related Peptide; Receptors, Cholinergic; Receptors, Neuropeptide; Receptors, Vasoactive Intestinal Peptide; Reverse Transcriptase Polymerase Chain Reaction; Simian virus 40; Thymoma; Thymus Gland; Vasoactive Intestinal Peptide

1999
Silent mixed ganglioneuroma/pheochromocytoma which produces a vasoactive intestinal polypeptide.
    Internal medicine (Tokyo, Japan), 1993, Volume: 32, Issue:1

    An unusual pheochromocytoma was incidentally discovered in a 48-year-old woman. The patient had a 3-year history of myasthenia gravis. At the time of examination in our hospital, the right adrenal tumor was incidentally discovered by ultrasonography of the abdomen. She had no history of headache, perspiration, palpitation or hypertension. Although blood catecholamine levels were within the normal limits, urinary secretion of catecholamine was elevated. Histologically, the tumor was diagnosed to be mixed ganglioneuroma/pheochromocytoma and histochemically confirmed to produce vasoactive intestinal polypeptide. Such a tumor is quite rare.

    Topics: Adrenal Gland Neoplasms; Catecholamines; Female; Ganglioneuroma; Humans; Middle Aged; Myasthenia Gravis; Pheochromocytoma; Vasoactive Intestinal Peptide

1993